Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma.

Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer. 2005 Apr 15; 103(8):1615-24.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal
Databases as Topic
Fertility Agents, Female
Gonadotropin-Releasing Hormone
Goserelin
Humans
Male
Neoplasm Staging
Orchiectomy
Predictive Value of Tests
Prostatic Neoplasms
Registries
SEER Program
Time Factors
Treatment Outcome

authors with profiles

J Shawn Goodwin

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support